Business Wire

Der hier verfügbare Newsfeed wird von unserem Content-Partner Business Wire bereitgestellt. Es handelt sich dabei um einen der bedeutendsten und reichweitenstärksten Pressedienste, die Nachrichten, Pressemitteilungen und Multimedia-Inhalte an Medien, Journalisten und der Öffentlichkeit zur Verfügung stellen. Business Wire ist ein Tochterunternehmen des Warren-Buffett-Konzerns Berkshire Hathaway.
Der NewsWire-Hub ("X-Billboard") umfasst derzeit vfünf der wichtigsten internationalen Nachrichtenquellen und wird durch einen Börseninformationsservice ergänzt. Die einzelnen Newswire-Services ergänzen sich und bilden ein komplementäres Informationsangebot, mehr als drei Viertel der offiziellen Nachrichtenquellen ab, auf die sich Redaktionen weltweit bei ihrer Börsenberichterstattung stützen. Ihr Vorteil: Sie finden hier alles in einer Übersicht. Über die Steuerelemente können Sie zu den einzelnen Bereichen navigieren. Im Terminalview können Sie gezielt auf Unternehmensebene individuelle Recherchen durchführen.
presented by
H
More Tools & Gadgets
Systemstatus: 15.977 Nachrichten wurden bislang erfolgreich verarbeitet
Business Wire ist eine wichtige Nachrichtenquelle, die über das X-Billboard abgerufen werden kann. Sie ist Teil des Newswire-Hub, der für Börsianer wichtige internationalen Nachrichtenquellen an einem zentralen Ort bündelt. Wer sich schnell einen Überblick verschaffen will, kann sich bequem durch die Headlines scrollen. Wer sich detailliert mit den Nachrichten auseinandersetzen möchte, kann über die Detailansichten der Info-Cards direkt auf die jeweilige Nachricht und weitere Analysewerkzeuge zugreifen.
NEWS
EXPLORER
Letzte Aktualisierung: 17.11.2024 | 6PM
Fr., 09.08.2024       Merck & Co.
US58933Y1055

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Curon Biopharmaceutical (Curon), a privately held biotechnology company, today announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, has agreed to acquire CN201, a novel investigational clinical-stage bispecific ant...
weiterlesen
Merck & Co.
Research & Analysen Termsheet Terminal
Permalink
Fr., 09.08.2024       Mobileye Global
US60741F1049

Mobileye Global Inc. (Nasdaq: MBLY) (“Mobileye”) announced today that it is scheduled to participate in the following upcoming investor events in the third quarter of 2024. Canaccord Genuity 44th Annual Growth Conference, August 13-15, 2024 Goldman Sachs Communacopia + Technology Conference, San Francisco, September 9-12, 2024 Evercore IS...
weiterlesen
Mobileye Global
Research & Analysen Termsheet Terminal
Permalink
Fr., 09.08.2024       Global Blue Group
CH0562152865

A sustained performance in Continental Europe for international shopping In Continental Europe, the issued Sales in Store growth rate grew by +12%1 in July 2024 vs. last year. This growth was led by a +10%1 increase in the number of shoppers and a +2%1 average spend per shopper. The deceleration in July’s growth rate (+12% in July vs. +19% in ...
weiterlesen
Global Blue Group
Research & Analysen Termsheet Terminal
Permalink
Fr., 09.08.2024       Amneal Pharma
US03168L1052

Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) announced its results today for the second quarter ended June 30, 2024. “Amneal achieved strong revenues and adjusted EBITDA in the second quarter, and we are pleased to raise full year 2024 guidance driven by broad-based growth across our business. Amneal is a diversified a...
weiterlesen
Amneal Pharma
Research & Analysen Termsheet Terminal
Permalink
Fr., 09.08.2024       Lululemon Athletica
US5500211090

The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of lululemon athletica inc. (NASDAQ: LULU) securities between December 7, 2023 and July 24, 2024, inclusive (the “Class Period”), have until October 7, 2024 to seek appointment as lead plaintiff of the lululemon class action lawsuit. Captioned Patel v. lulu...
weiterlesen
Lululemon Athletica
Research & Analysen Termsheet Terminal
Permalink
Fr., 09.08.2024       National HealthCare
US6359061008

National HealthCare Corporation (NYSE American: NHC), the nation's oldest publicly traded senior health care company, announced today net operating revenues and grant income for the quarter ended June 30, 2024 totaled $300,658,000 compared to $282,582,000 for the quarter ended June 30, 2023, an increase of 6.4%. Excluding the governmental stimulus...
weiterlesen
National HealthCare
Research & Analysen Termsheet Terminal
Permalink
Fr., 09.08.2024       Emera
CA2908761018

Today Emera Inc. (“Emera”) (TSX: EMA) reported financial results for the second quarter and year-to-date 2024. Highlights Growth in Reported Net Income Per Share (“EPS”)(1): Reported EPS saw a substantial increase of $0.35 to $0.45 in Q2 2024, compared to $0.10 in Q2 2023. This improvement was driven by a gain on the strategic sale of the Lab...
weiterlesen
Emera
Research & Analysen Termsheet Terminal
Permalink
Fr., 09.08.2024       Li-Cycle
CA50202P1053

Li-Cycle Holdings Corp. (NYSE: LICY) (“Li-Cycle” or the “Company”), a leading global lithium-ion battery resource recovery company, announced today that the Audit Committee of the Company’s Board of Directors (the “Board”) has unanimously approved the selection of Marcum Canada LLP (“Marcum”) as the Company’s independent registered public accounti...
weiterlesen
Li-Cycle
Research & Analysen Termsheet Terminal
Permalink
Fr., 09.08.2024       FREYR Battery
LU2360697374

FREYR Battery, Inc. (NYSE: FREY) (“FREYR” or the “Company”), a developer of sustainable, next-generation battery solutions, today reported financial results for the second quarter of 2024. Key Messages: FREYR’s new Board of Directors and leadership team executing plan to achieve first revenues and EBITDA as soon as 2025. The Company’s top pri...
weiterlesen
FREYR Battery
Research & Analysen Termsheet Terminal
Permalink
Fr., 09.08.2024       Mind Medicine
CA60255C8850

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that it intends to offer and sell, subject to market conditions, common shares and, to certain investors, pre-funded warrants to purchase common sh...
weiterlesen
Mind Medicine
Research & Analysen Termsheet Terminal
Permalink
Fr., 09.08.2024       Anaergia
CA03253E1079

Anaergia Inc. (“Anaergia”, the “Company”, “us”, or “our”) (TSX: ANRG) today announced its financial results for the three- and six-month periods ended June 30, 2024 (“Q2 2024”), and the related management’s discussion and analysis (“MD&A”) for the period. Certain highlights from these financial results and from the MD&A follow. All financi...
weiterlesen
Anaergia
Research & Analysen Termsheet Terminal
Permalink
Fr., 09.08.2024       New York City
US6494393043

American Strategic Investment Co. (NYSE: NYC) (“ASIC” or the “Company”), a company that owns a portfolio of commercial real estate located within the five boroughs of New York City, announced today its financial and operating results for the second quarter ended June 30, 2024. Second Quarter 2024 Highlights Revenue was stable at $15.8 million...
weiterlesen
New York City
Research & Analysen Termsheet Terminal
Permalink
Fr., 09.08.2024

Following Olympic gold medalists Pan Zhanle and Zheng Qinwen, the Chinese Artistic Swimming Team has made history by winning China's first-ever Olympic gold medal in artistic swimming! This historic breakthrough has ignited a wave of national pride and excitement, with millions of Chinese celebrating this momentous victory. This press release fea...
weiterlesen
Permalink
Fr., 09.08.2024       Iteris
US46564T1079

Iteris, Inc. (NASDAQ: ITI) (“Iteris” or the “Company”), the world’s trusted technology ecosystem for smart mobility infrastructure management, today announced that it has entered into a definitive merger agreement to be acquired by Almaviva S.p.A. (“Almaviva”), a private Italian digital innovation group, in an all-cash transaction valuing Iteris a...
weiterlesen
Iteris
Research & Analysen Termsheet Terminal
Permalink
Fr., 09.08.2024       Guidewire Software
US40171V1008

Guidewire (NYSE: GWRE) announced that Guidewire India, the company’s software development hub, has launched Guidewire Gives Back’s “ElevatEd by Guidewire” scholarship program in engineering exclusively for female college students from underprivileged backgrounds. “ElevatEd by Guidewire” is a transformative opportunity for talented, disadvantaged...
weiterlesen
Guidewire Software
Research & Analysen Termsheet Terminal
Permalink
Fr., 09.08.2024       XPEL
US98379L1008

Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of all purchasers of securities of XPEL, Inc. (NASDAQ: XPEL) between November 8, 2023 and May 2, 2024. XPEL describes itself as a company that “supplies automotive paint protection film, automotive window film, ceramic coatings, architect...
weiterlesen
XPEL
Research & Analysen Termsheet Terminal
Permalink
Fr., 09.08.2024

IGC Pharma, Inc. (“IGC” or the “Company”) (NYSE American: IGC) today announced its financial results for the first fiscal quarter of 2025 ended June 30, 2024. Q1 FY2025 Company’s Highlights On April 9, 2024, the Company welcomed Pablo Arbelaez, Ph.D., a renowned AI expert and researcher, to support the development of the Phase 2 clinical tria...
weiterlesen
Permalink
Fr., 09.08.2024       Slate Office Reit
CA8310211005

Slate Office REIT (TSX: SOT.UN) (the "REIT"), an owner and operator of high-quality workplace real estate, reported today financial results and highlights for the three and six months ended June 30, 2024. To access the REIT's Management Discussion and Analysis (MD&A), please follow the link here. Highlights The REIT completed 381,595 sq...
weiterlesen
Slate Office Reit
Research & Analysen Termsheet Terminal
Permalink
Fr., 09.08.2024       Customers Bancorp
US23204G1004

Shares of Customers Bancorp, Inc. (NYSE: CUBI) dropped over 14% in intraday trading on Thursday, August 8, 2024, after the Federal Reserve Board announced that it had issued an enforcement action with Customers Bancorp and its principal subsidiary, citing “significant deficiencies related to the Bank’s risk management practices and compliance with...
weiterlesen
Customers Bancorp
Research & Analysen Termsheet Terminal
Permalink
Fr., 09.08.2024       Outset Medical
US6901451079

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Outset Medical, Inc. (“Outset” or “the Company”) (NASDAQ: OM) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to di...
weiterlesen
Outset Medical
Research & Analysen Termsheet Terminal
Permalink

Die hier zur Verfügung gestellten Informationen unterliegen keiner redaktionellen Bearbeitung. Die Aufbereitung erfolgt vollautomatisch und wird durch Zusatzinformationen und weiterführende Recherchemöglichkeiten angereichert. Ziel der Inhalte ist die schnelle und unkomplizierte Versorgung der Informationssuchenden mit den für sie relevanten Informationen. Durch eine Rückverlinkung auf den Informationsanbieter und -eigentümer ist sichergestellt, dass die hier aufbereiteten Daten bei Bedarf mit den Quellinformationen abgeglichen werden können. Das Newsboard zeigt keine Informationen in Echtzeit. Diese bitten wir bei Bedarf beim Börsenbetreiber abzurufen. Es besteht kein Anspruch auf Vollständigkeit. Hochverfügbarkeit kann nicht gewährleistet werden. Sollten Sie Fehler in der Funktionsweise bemerken, teilen Sie uns diese über das weiter unten befindliche Formular "Report a Bug" mit.

RAW DATA PROCESSING bedeutet, dass Rohdaten verarbeitet werden, ohne den Inhalt zu verändern. Um die Interpretation der Information im Sinne der Nutzbarkeit zu verbessern, werden die Daten ergänzt. 

Hinweis: Über das Newswire-Crosslink-Panel im oberen Bereich gelangen Sie schnell und bequem zu weiteren Informationsquellen. Im Terminalview sind die Nachrichten auf Unternehmensebene gefiltert und ermöglich darüber gezielte Recherchen.

Wir bedanken uns im Namen der Investoren-Community bei BusinessWire für die Bereitstellung der News- und Datenfeeds